News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Drug-resistant TB news

Show

From To
Drug-resistant TB
HIV infection does not compromise multidrug-resistant TB treatment outcomes in Botswana

HIV infection did not have an impact on the time it took for people with multidrug-resistant tuberculosis (MDR-TB) to reach culture conversion, according to a study from

Published
27 July 2012
By
Lesley Odendal
TB treatment
Tuberculosis: Combined wisdom

Buried in the HIV frenzy at the International AIDS Conference was a rather important announcement for another blight, tuberculosis.

Published
26 July 2012
From
The Economist
TB treatment
Trial Signals Major Milestone in Hunt for New TB Drugs

A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients’ TB bacteria within two weeks and could be more effective than existing treatments. These results add to a growing body of evidence that the new regimen could reduce treatment by more than a year for some patients.

Published
24 July 2012
From
TB Alliance
Drug-resistant TB
Janssen Research & Development Submits New Drug Application to FDA for Investigational Multi-Drug Resistant Tuberculosis Treatment Bedaquiline (TMC207)

Janssen Research & Development, LLC (Janssen) today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval for the use of the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as part of combination therapy for pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults.

Published
02 July 2012
From
PR Newswire (press release)
Drug-resistant TB
SOUTH AFRICA: First nurses trained to initiate MDR-TB treatment

South Africa will increasingly move towards nurse-initiated treatment for multidrug-resistant tuberculosis (MDR-TB) in the next five years, and a programme in KwaZulu-Natal Province, which has a high HIV/TB burden, is already training nurses to manage MDR-TB patients.

Published
19 June 2012
From
IRIN Plus News
Drug-resistant TB
SOUTH AFRICA: Decentralizing care and treatment for drug-resistant TB

South Africa's move to decentralize the treatment of drug-resistant tuberculosis (TB) has given rise to a crop of nurses equipped not only to initiate patients on HIV treatment, but also to prescribe for and monitor drug-resistant TB (DR-TB) patients. However, experts and government officials say the need for specialist physicians and hospitals will continue, based on research presented at the South African TB conference in the port city of Durban.

Published
14 June 2012
From
IRIN Plus News
Drug-resistant TB
Drug-Resistant Tuberculosis A 'Serious Epidemic' In China

China's first national survey of tuberculosis has produced some of the worst TB news in years.

Published
08 June 2012
From
npr
TB diagnosis
New laboratory tests to enhance TB diagnosis: Microscopy, LAM and Xpert MTB/RIF used as a drug resistance test

The third in a series looking at the implications of new laboratory tests for TB diagnosis, particularly in people living with HIV.

Published
25 May 2012
From
HIV & AIDS treatment in practice
Drug-resistant TB
MDR-TB and the BRICS

At the 65th World Health Assembly, UNITAID held a technical briefing to propose a new paradigm for middle-income countries to drive multidrug-resistant tuberculosis (MDR-TB) markets for greater public health good

Published
25 May 2012
From
UNITAID
Global health initiatives
UNITAID seeks innovative HIV, TB and malaria proposals

UNITAID is inviting letters of intent (LOI), or short conceptual presentations of a proposed project, on the topic of improving access to key preventive, diagnostic and treatment commodities for HIV, tuberculosis (TB) and malaria through market-based approaches.  UNITAID works to negotiate low pricing for diagnostics and medication for AIDS, tuberculosis and malaria in developing countries.

Published
16 May 2012
From
Science Speaks
← Prev1...34567...11Next →

Filter by country